TAG ARCHIVES FOR webinar

29
Jun2018

Ten Steps to Embracing Diversity in IRBs and IACUCs Through the Art of Bread Making

Tags:
29 Jun
No comments

Duke Morrow, MDiv, DMin, one of the speakers of the recent PRIM&R webinar Exploring and Enhancing Diversity for IACUCs and IRBs, presented registrants with a helpful metaphor for conducting a comprehensive IRB/IACUC review of a proposal—bread making. Bread making is a step-by-step process that takes time, care, love, and some elbow grease. This wonderful analogy helped us understand the influence of diverse viewpoints as the “ingredients” for a complete review of research proposals. So, let us review IRB/IACUCs through the lens of making bread. Read more

20
Jun2018

Webinar Follow-Up: Forward-Looking Strategies for IRBs in the Genomic Age

Tags:
20 Jun
No comments

On May 10, PRIM&R hosted a webinar, Forward-Looking Strategies for IRBs in the Genomic Age: Preparing for Shifting Concepts of Identifiability, to provide expert input on the impact of breakthroughs in genomics research on traditional notions of identifiability.The panel consisted of Jiayan Chen, JD, a partner at McDermott Will & Emery, LLP, and Suzanne Rivera, PhD, MSW, vice president for research and technology management at Case Western Reserve University. After the webinar, Ms. Chen and Dr. Rivera responded to some of the attendee questions time didn’t permit us to address live. We’re pleased to share those responses with the readers of Ampersand. Read more

28
May2018

Webinar Follow-up: Digital Health Technology and Human Subjects Research – What IRBs Need to Know

Tags:
28 May
No comments

The rapid proliferation of new digital health applications, tools, and technologies is reshaping the health care and research environments. Companies that develop these products may not have strong foundations in health care norms and ethics standards, and, in the the absence of FDA oversight, these products may not have been developed with an explicit focus on safety and effectiveness. It is important for IRBs to have the knowledge and strategies for evaluating these tools' adequacy to protect the data, privacy, and confidentiality of research subjects in trials involving digital health technologies. On February 8, PRIM&R hosted the webinar to provide guidance for IRBs in the assessment of new technologies in the health care field. Presenters answer follow-up questions from the webinar for readers of Ampersand. Read more

26
Apr2018

Webinar Follow-up: Clarifying “Exceptions” and “Departures” – How to Identify, Track, and Report

Tags:
26 Apr
No comments

The Guide for the Care and Use of Laboratory Animals and the Animal Welfare Act Regulations describe rules and best practices for animal care and use professionals to follow in order to ensure high welfare standards are upheld for animals used in research. When an IACUC finds something that diverges from these regulations and standards, it can be a challenge to know whether and where to report the issue. To complicate matters, OLAW and USDA APHIS use differing terminology to describe these occurrences, and have different requirements for reporting. A solid, systematic framework for understanding, sorting, and managing “exceptions” and “departures” can help IACUC administrators more effectively sort through complex issues of compliance. Read more

26
Mar2018

Webinar Follow-up: SBER Across Borders

Tags:
26 Mar
No comments

Research conducted in international settings poses particular challenges for the reviewing IRB, as it must possess adequate knowledge of laws and regulations in the country where the research is taking place, and be sensitive to the area’s cultural norms, in order to appropriately evaluate the study. Social, behavioral, and educational research (SBER) in particular may involve the study of stigmatized health conditions or behaviors, and may require the recruitment of marginalized populations and minors. Conducting research on these topics is important, but it is equally essential that IRBs and researchers mitigate the risk of social consequences that might result from subjects’ participation in the study, such as rejection in their communities or conflict within their families. The regulations regarding human subjects protections vary greatly between countries as well, which can lead to additional difficulties for IRBs. Read more